FRAZIER MANAGEMENT LLC - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 26 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2020$408,000
-60.6%
199,953
-42.9%
0.04%
-59.3%
Q2 2020$1,036,000
-62.7%
349,953
-66.7%
0.09%
-71.1%
Q1 2020$2,775,000
-58.6%
1,049,953
-22.2%
0.32%
-72.0%
Q4 2019$6,709,000
-16.6%
1,349,9530.0%1.12%
-55.3%
Q3 2019$8,046,000
-7.6%
1,349,9530.0%2.52%
+12.8%
Q2 2019$8,707,000
-4.5%
1,349,9530.0%2.23%
+1.6%
Q1 2019$9,119,000
+66.0%
1,349,9530.0%2.20%
+54.8%
Q4 2018$5,494,000
-62.6%
1,349,9530.0%1.42%
-47.3%
Q3 2018$14,687,0001,349,9532.69%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q4 2020
NameSharesValueWeighting ↓
GARDNER LEWIS ASSET MANAGEMENT L P 1,249,778$2,750,0000.55%
Beryl Capital Management LLC 1,131,772$2,490,0000.26%
DELTEC ASSET MANAGEMENT LLC 155,614$342,0000.08%
Knott David M Jr 41,700$92,0000.04%
TPG GP A, LLC 1,020,748$2,246,0000.04%
GABELLI & Co INVESTMENT ADVISERS, INC. 40,900$90,0000.01%
Ergoteles LLC 135,323$298,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,600$292,0000.01%
Virtu Financial LLC 20,027$44,0000.00%
GABELLI FUNDS LLC 59,100$130,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders